| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |